NCT03589313View on ClinicalTrials.gov

Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

GLPG3067 single dose

GLPG3067 film coated tablets provided at Day 1.

Trial Locations (1)

Unknown

University Hospital Leuven,Pediatric Pulmonology, Leuven

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY

NCT03589313 - Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis. | Biotech Hunter | Biotech Hunter